Alvotech (ALVOW) Non-Current Assets (2020 - 2025)
Alvotech (ALVOW) reported Non-Current Assets of $913.1 million for Q4 2025, up 19.14% on a YoY basis from $766.4 million in Q4 2024, and down 6.56% quarter-over-quarter from $977.2 million in Q3 2025.
Alvotech (ALVOW) Non-Current Assets (2020 - 2025) Analysis & Trends
Alvotech has reported Non-Current Assets for 6 years, with the latest figure at $913.1 million in Q4 2025.
- For the quarter ending Q4 2025, Non-Current Assets rose 19.14% year-over-year to $913.1 million; the trailing twelve-month figure through Dec 2025 stood at $913.1 million (up 19.14% YoY), and the FY2025 full-year result was $913.1 million, up 19.14% from the prior year.
- Non-Current Assets for Q4 2025 stood at $913.1 million, down from $977.2 million in the prior quarter.
- The five-year high for Non-Current Assets was $977.2 million in Q3 2025, with the low at $478.2 million in Q4 2021.
- Historically, Non-Current Assets has averaged $740.8 million across 5 years, with a median of $767.4 million in 2024.
- Annual changes were most pronounced in 2023 — Non-Current Assets soared 30.4% — and 2024, when it rose 1.47%.
- Alvotech's Non-Current Assets stood at $478.2 million in 2021, then increased by 25.0% to $597.7 million in 2022, then gained by 26.36% to $755.2 million in 2023, then advanced by 1.47% to $766.4 million in 2024, then rose by 19.14% to $913.1 million in 2025.
- The last three Non-Current Assets figures came in at $913.1 million (Q4 2025), $977.2 million (Q3 2025), and $883.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | Alvotech | - | - | -22.39 Mn | 913.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 913.08 Mn |
| Sep 30, 2025 | 977.17 Mn |
| Jun 30, 2025 | 883.29 Mn |
| Mar 31, 2025 | 786.59 Mn |
| Dec 31, 2024 | 766.38 Mn |
| Sep 30, 2024 | 800.34 Mn |
| Jun 30, 2024 | 783.29 Mn |
| Mar 31, 2024 | 768.34 Mn |
| Dec 31, 2023 | 755.25 Mn |
| Jun 30, 2023 | 698.75 Mn |
| Mar 31, 2023 | 626.32 Mn |
| Dec 31, 2022 | 597.71 Mn |
| Jun 30, 2022 | 535.84 Mn |
| Dec 31, 2021 | 478.16 Mn |
| Dec 31, 2020 | 388.26 Mn |